Skip to main content
. 2023 Jun 5;2023(6):CD014915. doi: 10.1002/14651858.CD014915.pub2

Comparison 2. Experimental studies with synthetic tetrahydrocannabinol (THC) analogue versus placebo for individuals with cancer pain.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Mean pain intensity 4 301 Std. Mean Difference (IV, Random, 95% CI) ‐0.98 [‐1.36, ‐0.60]
2.1.1 Synthetic THC analogue 5 mg and 10 mg 4 193 Std. Mean Difference (IV, Random, 95% CI) ‐0.77 [‐1.19, ‐0.35]
2.1.2 Synthetic THC analogue 15 mg and 20 mg 2 108 Std. Mean Difference (IV, Random, 95% CI) ‐1.42 [‐2.23, ‐0.62]